ATE332130T1 - Fab-i-hemmer - Google Patents
Fab-i-hemmerInfo
- Publication number
- ATE332130T1 ATE332130T1 AT00968801T AT00968801T ATE332130T1 AT E332130 T1 ATE332130 T1 AT E332130T1 AT 00968801 T AT00968801 T AT 00968801T AT 00968801 T AT00968801 T AT 00968801T AT E332130 T1 ATE332130 T1 AT E332130T1
- Authority
- AT
- Austria
- Prior art keywords
- 6alkyl
- 4alkyl
- substituted
- fab
- membered
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15870799P | 1999-10-08 | 1999-10-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE332130T1 true ATE332130T1 (de) | 2006-07-15 |
Family
ID=22569347
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00968801T ATE332130T1 (de) | 1999-10-08 | 2000-10-06 | Fab-i-hemmer |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1225894B1 (de) |
JP (1) | JP4831907B2 (de) |
AT (1) | ATE332130T1 (de) |
AU (1) | AU7866300A (de) |
CO (1) | CO5251397A1 (de) |
DE (1) | DE60029235T2 (de) |
ES (1) | ES2270874T3 (de) |
WO (1) | WO2001026652A1 (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CO5180550A1 (es) | 1999-04-19 | 2002-07-30 | Smithkline Beecham Corp | Inhibidores de fab i |
AR024158A1 (es) | 1999-06-01 | 2002-09-04 | Smithkline Beecham Corp | Compuestos antibacterianos |
ATE285821T1 (de) | 1999-10-08 | 2005-01-15 | Affinium Pharm Inc | Fab i inhibitoren |
US6762201B1 (en) | 1999-10-08 | 2004-07-13 | Affinium Pharmaceuticals, Inc. | Fab I inhibitors |
US6730684B1 (en) | 1999-10-08 | 2004-05-04 | Affinium Pharmaceuticals, Inc. | Fab I inhibitors |
WO2002028839A1 (en) * | 2000-10-06 | 2002-04-11 | Neurogen Corporation | Benzimidazole and indole derivatives as crf receptor modulators |
KR100406634B1 (ko) * | 2001-03-12 | 2003-11-20 | 주식회사 엘지생명과학 | 3,5-디아미노인다졸 유도체, 그의 제조방법 및 사이클린의존성 키나아제 저해제로서의 그의 용도 |
CA2444597A1 (en) | 2001-04-06 | 2002-10-06 | Affinium Pharmaceuticals, Inc. | Fab i inhibitors |
SE0102299D0 (sv) | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
JP4859460B2 (ja) * | 2002-12-06 | 2012-01-25 | アフィニウム ファーマシューティカルズ, インク. | ヘテロ環化合物、その製造方法および治療におけるその使用 |
ATE409485T1 (de) * | 2003-03-17 | 2008-10-15 | Affinium Pharm Inc | Pharmazeutische zusammensetzungen inhibitoren von fab i und weitere antibiotika enthaltend |
WO2005033079A1 (ja) | 2003-09-30 | 2005-04-14 | Eisai Co., Ltd. | ヘテロ環化合物を含有する新規な抗真菌剤 |
WO2006106711A1 (ja) * | 2005-03-30 | 2006-10-12 | Eisai R & D Management Co., Ltd. | ピリジン誘導体を含有する抗真菌剤 |
MX2007012659A (es) * | 2005-04-13 | 2008-01-11 | Astex Therapeutics Ltd | Derivados de hidroxi-benzamida y su uso como inhibidores de hsp90. |
TWI385169B (zh) | 2005-10-31 | 2013-02-11 | Eisai R&D Man Co Ltd | 經雜環取代之吡啶衍生物及含有彼之抗真菌劑 |
EP2687533B1 (de) | 2006-07-20 | 2017-07-19 | Debiopharm International SA | Acrylamidderivate als FAB-I-Hemmer |
EP2065377B1 (de) | 2006-09-21 | 2011-11-23 | Eisai R&D Management Co., Ltd. | Durch einen heteroarylring substituiertes pyridinderivat und antipilzmittel, das dieses enthält |
EP3255045A1 (de) | 2007-02-16 | 2017-12-13 | Debiopharm International SA | Salze, prodrugs und polymorphe von fab i-inhibitoren |
TW200841879A (en) | 2007-04-27 | 2008-11-01 | Eisai R&D Man Co Ltd | Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same |
JPWO2008136279A1 (ja) | 2007-04-27 | 2010-07-29 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ヘテロ環置換ピリジン誘導体の塩またはその結晶 |
US8513287B2 (en) | 2007-12-27 | 2013-08-20 | Eisai R&D Management Co., Ltd. | Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same |
US8188119B2 (en) | 2008-10-24 | 2012-05-29 | Eisai R&D Management Co., Ltd | Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same |
AU2012293618B2 (en) | 2011-08-10 | 2017-04-20 | Janssen Sciences Ireland Uc | Antibacterial homopiperidinyl substituted 3,4 dihydro 1H (1,8)naphthyridinones |
KR101967174B1 (ko) | 2011-08-10 | 2019-04-09 | 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 | 항균성 피페리디닐 치환 3,4-디하이드로-1h-[1,8]나프티리디논 |
JO3611B1 (ar) | 2011-08-10 | 2020-08-27 | Janssen Sciences Ireland Uc | سايكلو بنتا (سي (بيرول 4,3 ثاني هيدرو 1 hمستبدله [8,1] نافثيريدينونات مضادة للجراثيم |
JP6085026B2 (ja) | 2012-06-19 | 2017-02-22 | デビオファーム インターナショナル エスエーDebiopharm International Sa | (e)−n−メチル−n−((3−メチルベンゾフラン−2−イル)メチル)−3−(7−オキソ−5,6,7,8−テトラヒドロ−1,8−ナフチリジン−3−イル)アクリルアミドのプロドラッグ誘導体 |
AU2013301451B2 (en) | 2012-08-10 | 2017-09-14 | Janssen Sciences Ireland Uc | New antibacterial compounds |
ES2634999T3 (es) | 2012-08-10 | 2017-10-02 | Janssen Sciences Ireland Uc | Nuevos compuestos antibacterianos |
CA3014541A1 (en) | 2016-02-26 | 2017-08-31 | Debiopharm International S.A. | Medicament for treatment of diabetic foot infections |
SG11201908351TA (en) * | 2017-03-10 | 2019-10-30 | Edmond J Lavoie | Indole derivatives as efflux pump inhibitors |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3828068A (en) * | 1971-05-10 | 1974-08-06 | Tenneco Chem | ((substituted indazolyl)-n1-methyl)carbamates |
FR2692575B1 (fr) * | 1992-06-23 | 1995-06-30 | Sanofi Elf | Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
JP2001518094A (ja) * | 1997-03-31 | 2001-10-09 | デュポン ファーマシューティカルズ カンパニー | Hivプロテアーゼ阻害剤として有用なインダゾール−環式尿素 |
CO5180550A1 (es) * | 1999-04-19 | 2002-07-30 | Smithkline Beecham Corp | Inhibidores de fab i |
AR024158A1 (es) * | 1999-06-01 | 2002-09-04 | Smithkline Beecham Corp | Compuestos antibacterianos |
AU1192501A (en) * | 1999-10-08 | 2001-04-23 | Smithkline Beecham Corporation | Fab i inhibitors |
ATE285821T1 (de) * | 1999-10-08 | 2005-01-15 | Affinium Pharm Inc | Fab i inhibitoren |
-
2000
- 2000-10-06 DE DE60029235T patent/DE60029235T2/de not_active Expired - Lifetime
- 2000-10-06 AU AU78663/00A patent/AU7866300A/en not_active Abandoned
- 2000-10-06 WO PCT/US2000/027619 patent/WO2001026652A1/en active IP Right Grant
- 2000-10-06 AT AT00968801T patent/ATE332130T1/de not_active IP Right Cessation
- 2000-10-06 JP JP2001529442A patent/JP4831907B2/ja not_active Expired - Fee Related
- 2000-10-06 EP EP00968801A patent/EP1225894B1/de not_active Expired - Lifetime
- 2000-10-06 CO CO00076099A patent/CO5251397A1/es unknown
- 2000-10-06 ES ES00968801T patent/ES2270874T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1225894A1 (de) | 2002-07-31 |
EP1225894B1 (de) | 2006-07-05 |
JP4831907B2 (ja) | 2011-12-07 |
WO2001026652A1 (en) | 2001-04-19 |
EP1225894A4 (de) | 2003-01-08 |
CO5251397A1 (es) | 2003-02-28 |
JP2003511414A (ja) | 2003-03-25 |
ES2270874T3 (es) | 2007-04-16 |
DE60029235D1 (en) | 2006-08-17 |
AU7866300A (en) | 2001-04-23 |
DE60029235T2 (de) | 2007-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE332130T1 (de) | Fab-i-hemmer | |
CO5251401A1 (es) | Inhibidores de fab i | |
DK1392666T3 (da) | Biologisk aktive methylenblåt-derivater | |
TR200103485T2 (tr) | Antibakteriyel bileşikler. | |
WO2001072728A3 (en) | Novel piperazine derivatives | |
TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
RS50140B (sr) | Postupak za dobijanje perkihinina i njegova upotreba | |
WO2002057252A3 (en) | Heterocyclic sulfonamide inhibitors of beta amyloid production | |
DK0977741T3 (da) | Substituerede phenylderivater, deres fremstilling og anvendelse | |
WO2000059902A3 (en) | Aryl sulfonyls as factor xa inhibitors | |
JO2311B1 (en) | Alkyl inhibitors Ariel phosphodiesterase-4 | |
NO996108L (no) | 9-oksinerytromycinderivater | |
ATE465146T1 (de) | 1h-indolderivate als hochselektive cyclooxygenase-2-inhibitoren | |
NO20062074L (no) | Forbindelse og fremgangsmater for a behandle dyslipidemi | |
SE0101932D0 (sv) | Pharmaceutical combinations | |
WO2003049690A3 (en) | Hiv integrase inhibitors | |
WO2003053971A8 (en) | Pyridoquinoxaline antivirals | |
WO2002032901A3 (en) | Bridged piperazine derivatives | |
DE60111774D1 (de) | Antibakterielle verbindungen | |
ID24846A (id) | Turunan-turunan bifenilamidina | |
ATE390923T1 (de) | Topoisomerase-giftmittel | |
ATE360612T1 (de) | In 4-stellung substituierte piperidinderivate | |
ATE348800T1 (de) | 4'-methansulfonylbiphenylderivate als hochselektive cyclooxygenase-2-inhibitoren | |
IL157440A0 (en) | Triazole derivatives and pharmaceutical compositions containing the same | |
NO20055015L (no) | T-type calcium kanalblokkere |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |